4.6 Article

Human extraintestinal pathogenic Escherichia coli strains differ in prevalence of virulence factors, phylogroups, and bacteriocin determinants

期刊

BMC MICROBIOLOGY
卷 16, 期 -, 页码 -

出版社

BIOMED CENTRAL LTD
DOI: 10.1186/s12866-016-0835-z

关键词

Escherichia coli; ExPEC; Colicin; Microcin; Virulence factor; Bacteriocinogeny

资金

  1. Grant Agency of the Czech Republic [16-21649S]
  2. Ministry of Health of the Czech Republic [NT13413-4/2012]

向作者/读者索取更多资源

Background: The study used a set of 407 human extraintestinal pathogenic E. coli strains (ExPEC) isolated from (1) skin and soft tissue infections, (2) respiratory infections, (3) intra-abdominal infections, and (4) genital smears. The set was tested for bacteriocin production, for prevalence of bacteriocin and virulence determinants, and for phylogenetic typing. Results obtained from the group of ExPEC strains were compared to data from our previously published analyses of 1283 fecal commensal E. coli strains. Results: The frequency of bacteriocinogeny was significantly higher in the set of ExPEC strains (63.1 %), compared to fecal E. coli (54.2 %; p < 0.01). Microcin producers and microcin determinants dominated in ExPEC strains, while colicin producers and colicin determinants were more frequent in fecal E. coli (p < 0.01). Higher production of microcin M and lower production of microcin B17, colicin Ib, and Js was detected in the set of ExPEC strains. ExPEC strains had a significantly higher prevalence of phylogenetic group B2 (52.6 %) compared to fecal E. coli strains (38.3 %; p < 0.01). Conclusions: Human ExPEC strains were shown to differ from human fecal strains in a number of parameters including bacteriocin production, prevalence of several bacteriocin and virulence determinants, and prevalence of phylogenetic groups. Differences in these parameters were also identified within subgroups of ExPEC strains of diverse origin. While some microcin determinants (mM, mH47) were associated with virulent strains, other bacteriocin types (mB17, Ib, and Js) were associated with fecal flora.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Microbiology

Colicins U and Y inhibit growth of Escherichia coli strains via recognition of conserved OmpA extracellular loop 1

Juraj Bosak, Lenka Micenkova, Magda Dolezalova, David Smajs

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2016)

Article Microbiology

Human Escherichia coli isolates from hemocultures: Septicemia linked to urogenital tract infections is caused by isolates harboring more virulence genes than bacteraemia linked to other conditions

Lenka Micenkova, Alzbeta Benova, Lucia Frankovicova, Juraj Bosak, Martin Vrba, Alena Sevcikova, Marta Kmet'ova, David Smajs

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2017)

Article Microbiology

Escherichia coli isolates from patients with inflammatory bowel disease: ExPEC virulence- and colicin-determinants are more frequent compared to healthy controls

Lenka Micenkova, Lucia Frankovicova, Iva Jabornikova, Juraj Bosak, Petr Dite, Jan Smarda, Martin Vrba, Alena Sevcikova, Marta Kmet'ova, David Smajs

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2018)

Article Veterinary Sciences

Characterization of four Escherichia albertii isolates collected from animals living in Antarctica and Patagonia

Linda Grillova, Ivo Sedlacek, Gabriela Pachnikova, Eva Stankova, Pavel Svec, Pavla Holochova, Lenka Micenkova, Juraj Bosak, Iva Slaninova, David Smajs

JOURNAL OF VETERINARY MEDICAL SCIENCE (2018)

Article Microbiology

Extensive Genetic Commonality among Wildlife, Wastewater, Community, and Nosocomial Isolates of Escherichia coli Sequence Type 131 (H30R1 and H30Rx Subclones) That Carry blaCTX-M-27 or blaCTX-M-15

Ivana Jamborova, Brian D. Johnston, Ivo Papousek, Katerina Kachlikova, Lenka Micenkova, Connie Clabots, Anna Skalova, Katerina Chudejova, Monika Dolejska, Ivan Literak, James R. Johnson

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Article Multidisciplinary Sciences

Colicin FY inhibits pathogenic Yersinia enterocolitica in mice

Juraj Bosak, Lenka Micenkova, Matej Hrala, Katarina Pomorska, Michaela Kunova Bosakova, Pavel Krejci, Eduard Gopfert, Martin Faldyna, David Smajs

SCIENTIFIC REPORTS (2018)

Article Biotechnology & Applied Microbiology

The Effect of Butyrate-Supplemented Parenteral Nutrition on Intestinal Defence Mechanisms and the Parenteral Nutrition-Induced Shift in the Gut Microbiota in the Rat Model

Zuzana Jirsova, Marie Heczkova, Helena Dankova, Hana Malinska, Petra Videnska, Hana Vespalcova, Lenka Micenkova, Lenka Bartonova, Eva Sticova, Alena Lodererova, Lucia Prefertusova, Alena Sekerkova, Jaromir Hradecky, Monika Cahova

BIOMED RESEARCH INTERNATIONAL (2019)

Article Microbiology

Porcine pathogenic Escherichia coli strains differ from human fecal strains in occurrence of bacteriocin types

Juraj Bosak, Matej Hrala, Viktoria Pirkova, Lenka Micenkova, Alois Cizek, Jiri Smola, Dana Kucerova, Zdenka Vackova, Eva Budinska, Ivana Kolackova, David Smajs

VETERINARY MICROBIOLOGY (2019)

Article Biotechnology & Applied Microbiology

Administration of the ProbioticEscherichia coliStrain A0 34/86 Resulted in a Stable Colonization of the Human Intestine During the First Year of Life

Lenka Micenkova, Juraj Bosak, Stanislav Smatana, Adam Novotny, Eva Budinska, David Smajs

PROBIOTICS AND ANTIMICROBIAL PROTEINS (2020)

Article Multidisciplinary Sciences

Colicin Z, a structurally and functionally novel colicin type that selectively kills enteroinvasive Escherichia coli and Shigella strains

Lenka Micenkova, Juraj Bosak, Jiri Kucera, Matej Hrala, Tereza Dolejsova, Ondrej Sedo, Dirk Linke, Radovan Fiser, David Smajs

SCIENTIFIC REPORTS (2019)

Article Multidisciplinary Sciences

Stool sampling and DNA isolation kits affect DNA quality and bacterial composition following 16S rRNA gene sequencing using MiSeq Illumina platform

Petra Videnska, Kristyna Smerkova, Barbora Zwinsova, Vlad Popovici, Lenka Micenkova, Karel Sedlar, Eva Budinska

SCIENTIFIC REPORTS (2019)

Review Infectious Diseases

Non-antibiotic antibacterial peptides and proteins ofEscherichia coli: efficacy and potency of bacteriocins

Juraj Bosak, Matej Hrala, Lenka Micenkova, David Smajs

Summary: Bacteriocins, peptides or proteins with relatively narrow spectra of antibacterial activities produced by various bacterial species, represent a potential alternative to antibiotic treatment. They have potential applications in human and animal medicine, as well as in the food industry.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2021)

Article Microbiology

Pseudomonas karstica sp. nov. and Pseudomonas spelaei sp. nov., isolated from calcite moonmilk deposits from caves

Pavel Svec, Marcel Kosina, Michal Zeman, Pavla Holochova, Stanislava Kralova, Eva Nemcova, Lenka Micenkova, Urvashi, Vipin Gupta, Utkarsh Sood, Rup Lal, Suresh Korpole, Ivo Sedlacek

INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2020)

Article Microbiology

Hymenobacter terrestris sp. nov. and Hymenobacter lapidiphilus sp. nov., isolated from regoliths in Antarctica

Ivo Sedlacek, Roman Pantucek, Michal Zeman, Pavla Holochova, Ondrej Sedo, Eva Stankova, Pavel Svec, Stanislava Kralova, Petra Videnska, Lenka Micenkova, Urvashi, Suresh Korpole, Rup Lal

INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2020)

暂无数据